Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Anticancer Research|June 25, 2003
A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinomaF Dagnaes-Hansen, L M Rasmussen, R Tilton, et al.
Diabetologia|September 17, 2009
Medial arterial calcification in diabetes and its relationship to neuropathyW J Jeffcoate, L M Rasmussen, L C Hofbauer, et al.
Anticancer Research|March 2, 2005
Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude miceF Dagnaes-Hansen, H Duan, L M Rasmussen, et al.
The Laryngoscope|February 24, 2001
How does endotoxin trigger inflammation in otitis media with effusion?L P Schousboe, T Ovesen, L Eckhardt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 12, 2010
Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patientsM Nybo, M K Poulsen, J Grauslund, et al.
Clinical Chemistry|April 1, 1997
Development of a urodilatin-specific antibody and radioimmunoassay for urodilatin in human urineJ Carstens, K T Jensen, P Ivarsen, et al.
The Journal of Molecular Diagnostics : JMD|August 4, 2001
Laser-assisted microdissection of membrane-mounted paraffin sections for polymerase chain reaction analysis: identification of cell populations using immunohistochemistry and in situ hybridizationL M Gjerdrum, I Lielpetere, L M Rasmussen, et al.
Journal of Vascular Surgery|March 1, 1995
Nitroglycerin decreases medial smooth muscle cell proliferation after arterial balloon injuryY G Wolf, L M Rasmussen, Y Sherman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 14, 2011
The relationship between HbA1c and fasting plasma glucose in patients with increased plasma liver enzyme measurementsR Christiansen, L M Rasmussen, L Melholt Rasmussen, et al.
Diabetologia|August 23, 2008
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathyA Jorsal, L Tarnow, A Flyvbjerg, et al.
Pageof 7